Literature DB >> 23698296

Recombinant IgA is sufficient to prevent influenza virus transmission in guinea pigs.

Christopher W Seibert1, Saad Rahmat, Jens C Krause, Dirk Eggink, Randy A Albrecht, Peter H Goff, Florian Krammer, J Andrew Duty, Nicole M Bouvier, Adolfo García-Sastre, Peter Palese.   

Abstract

A serum hemagglutination inhibition (HAI) titer of 40 or greater is thought to be associated with reduced influenza virus pathogenesis in humans and is often used as a correlate of protection in influenza vaccine studies. We have previously demonstrated that intramuscular vaccination of guinea pigs with inactivated influenza virus generates HAI titers greater than 300 but does not protect vaccinated animals from becoming infected with influenza virus by transmission from an infected cage mate. Only guinea pigs intranasally inoculated with a live influenza virus or a live attenuated virus vaccine, prior to challenge, were protected from transmission (A. C. Lowen et al., J. Virol. 83:2803-2818, 2009.). Because the serum HAI titer is mostly determined by IgG content, these results led us to speculate that prevention of viral transmission may require IgA antibodies or cellular immune responses. To evaluate this hypothesis, guinea pigs and ferrets were administered a potent, neutralizing mouse IgG monoclonal antibody, 30D1 (Ms 30D1 IgG), against the A/California/04/2009 (H1N1) virus hemagglutinin and exposed to respiratory droplets from animals infected with this virus. Even though HAI titers were greater than 160 1 day postadministration, Ms 30D1 IgG did not prevent airborne transmission to passively immunized recipient animals. In contrast, intramuscular administration of recombinant 30D1 IgA (Ms 30D1 IgA) prevented transmission to 88% of recipient guinea pigs, and Ms 30D1 IgA was detected in animal nasal washes. Ms 30D1 IgG administered intranasally also prevented transmission, suggesting the importance of mucosal immunity in preventing influenza virus transmission. Collectively, our data indicate that IgG antibodies may prevent pathogenesis associated with influenza virus infection but do not protect from virus infection by airborne transmission, while IgA antibodies are more important for preventing transmission of influenza viruses.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23698296      PMCID: PMC3700183          DOI: 10.1128/JVI.00979-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Universal PCR amplification of mouse immunoglobulin gene variable regions: the design of degenerate primers and an assessment of the effect of DNA polymerase 3' to 5' exonuclease activity.

Authors:  Z Wang; M Raifu; M Howard; L Smith; D Hansen; R Goldsby; D Ratner
Journal:  J Immunol Methods       Date:  2000-01-13       Impact factor: 2.303

2.  The guinea pig as a transmission model for human influenza viruses.

Authors:  Anice C Lowen; Samira Mubareka; Terrence M Tumpey; Adolfo García-Sastre; Peter Palese
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-19       Impact factor: 11.205

3.  Ferrets as a transmission model for influenza: sequence changes in HA1 of type A (H3N2) virus.

Authors:  M L Herlocher; S Elias; R Truscon; S Harrison; D Mindell; C Simon; A S Monto
Journal:  J Infect Dis       Date:  2001-08-02       Impact factor: 5.226

4.  Live attenuated versus inactivated influenza vaccine in infants and young children.

Authors:  Robert B Belshe; Kathryn M Edwards; Timo Vesikari; Steven V Black; Robert E Walker; Micki Hultquist; George Kemble; Edward M Connor
Journal:  N Engl J Med       Date:  2007-02-15       Impact factor: 91.245

5.  Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets.

Authors:  M Louise Herlocher; Rachel Truscon; Stephanie Elias; Hui-Ling Yen; Noel A Roberts; Suzanne E Ohmit; Arnold S Monto
Journal:  J Infect Dis       Date:  2004-09-28       Impact factor: 5.226

6.  Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract.

Authors:  Kathryn B Renegar; Parker A Small; Lou G Boykins; Peter F Wright
Journal:  J Immunol       Date:  2004-08-01       Impact factor: 5.422

7.  Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope.

Authors:  Gilad Ofek; Min Tang; Anna Sambor; Hermann Katinger; John R Mascola; Richard Wyatt; Peter D Kwong
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

8.  Serum antibody prevents lethal murine influenza pneumonitis but not tracheitis.

Authors:  R Ramphal; R C Cogliano; J W Shands; P A Small
Journal:  Infect Immun       Date:  1979-09       Impact factor: 3.441

9.  Receptor-mediated immunoglobulin G transport across mucosal barriers in adult life: functional expression of FcRn in the mammalian lung.

Authors:  Gerburg M Spiekermann; Patricia W Finn; E Sally Ward; Jennifer Dumont; Bonny L Dickinson; Richard S Blumberg; Wayne I Lencer
Journal:  J Exp Med       Date:  2002-08-05       Impact factor: 14.307

10.  Influenza virus transmission is dependent on relative humidity and temperature.

Authors:  Anice C Lowen; Samira Mubareka; John Steel; Peter Palese
Journal:  PLoS Pathog       Date:  2007-10-19       Impact factor: 6.823

View more
  42 in total

1.  Assessment of influenza virus hemagglutinin stalk-based immunity in ferrets.

Authors:  Florian Krammer; Rong Hai; Mark Yondola; Gene S Tan; Victor H Leyva-Grado; Alex B Ryder; Matthew S Miller; John K Rose; Peter Palese; Adolfo García-Sastre; Randy A Albrecht
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

2.  M2e-tetramer-specific memory CD4 T cells are broadly protective against influenza infection.

Authors:  D G Eliasson; A Omokanye; K Schön; U A Wenzel; V Bernasconi; M Bemark; A Kolpe; K El Bakkouri; T Ysenbaert; L Deng; W Fiers; X Saelens; N Lycke
Journal:  Mucosal Immunol       Date:  2017-03-01       Impact factor: 7.313

3.  Intranasal immunization with influenza antigens conjugated with cholera toxin subunit B stimulates broad spectrum immunity against influenza viruses.

Authors:  Junwei Li; Maria T Arévalo; Yanping Chen; Olivia Posadas; Jacob A Smith; Mingtao Zeng
Journal:  Hum Vaccin Immunother       Date:  2014-03-14       Impact factor: 3.452

4.  Broadly neutralizing anti-influenza virus antibodies: enhancement of neutralizing potency in polyclonal mixtures and IgA backbones.

Authors:  Wenqian He; Caitlin E Mullarkey; J Andrew Duty; Thomas M Moran; Peter Palese; Matthew S Miller
Journal:  J Virol       Date:  2015-01-14       Impact factor: 5.103

5.  Selective induction of antibody effector functional responses using MF59-adjuvanted vaccination.

Authors:  Carolyn M Boudreau; Wen-Han Yu; Todd J Suscovich; H Keipp Talbot; Kathryn M Edwards; Galit Alter
Journal:  J Clin Invest       Date:  2020-02-03       Impact factor: 14.808

6.  Hemagglutinin Stalk Immunity Reduces Influenza Virus Replication and Transmission in Ferrets.

Authors:  Raffael Nachbagauer; Matthew S Miller; Rong Hai; Alex B Ryder; John K Rose; Peter Palese; Adolfo García-Sastre; Florian Krammer; Randy A Albrecht
Journal:  J Virol       Date:  2015-12-30       Impact factor: 5.103

7.  Replication and Transmission of the Novel Bovine Influenza D Virus in a Guinea Pig Model.

Authors:  Chithra Sreenivasan; Milton Thomas; Zizhang Sheng; Ben M Hause; Emily A Collin; David E B Knudsen; Angela Pillatzki; Eric Nelson; Dan Wang; Radhey S Kaushik; Feng Li
Journal:  J Virol       Date:  2015-09-16       Impact factor: 5.103

8.  Retinol binding protein and vitamin D associations with serum antibody isotypes, serum influenza virus-specific neutralizing activities and airway cytokine profiles.

Authors:  B G Jones; C M Oshansky; R Bajracharya; L Tang; Y Sun; S S Wong; R Webby; P G Thomas; J L Hurwitz
Journal:  Clin Exp Immunol       Date:  2015-11-24       Impact factor: 4.330

9.  Heterosubtypic antibodies to influenza A virus have limited activity against cell-bound virus but are not impaired by strain-specific serum antibodies.

Authors:  Arkadiusz Wyrzucki; Matteo Bianchi; Ines Kohler; Marco Steck; Lars Hangartner
Journal:  J Virol       Date:  2014-12-31       Impact factor: 5.103

10.  Sequential Infection in Ferrets with Antigenically Distinct Seasonal H1N1 Influenza Viruses Boosts Hemagglutinin Stalk-Specific Antibodies.

Authors:  Greg A Kirchenbaum; Donald M Carter; Ted M Ross
Journal:  J Virol       Date:  2015-11-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.